L'archivio delle pubblicazioni di Fondazione ICONA

2022

Trickey A, Zhang L, Gill MJ, Bonnet F, Burkholder G, Castagna A, Cavassini M, Cichon P, Crane H, Domingo P, Grabar S, Guest JL, Obel N, Psichogiou M, Rava M, Reiss P, Rentsch CT, Riera M, Schuettfort G, Silverberg MJ, Sterne JAC Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort study. Lancet HIV. June 2022

2021

Johnson LF, Kariminia A, Trickey A, Yiannoutsos CT, Ekouevi DK, Minga AK, Pascom ARP, Han WM, Zhang L, Althoff KN, Rebeiro PF, Murenzi G, Ross J, Hsiao NY, Marsh K Achieving consistency in measures of HIV-1 viral suppression across countries: derivation of an adjustment based on international antiretroviral treatment cohort data. Journal of the International AIDS Society, 21 September 2021

2020

Trickey A, May MT, Gill MJ, Grabar S, Vehreschild J, Wit FWNM, Bonnet F, Cavassini M, Abgrall S, Berenguer J, Wyen C, Reiss P, Grabmeier-Pfistershammer K, Guest JL, Shepherd L, Teira R, d'Arminio Monforte A, del Amo J, Justice A, Costagliola D, Sterne JACS; The Antiretroviral Therapy Cohort Collaboration (ART-CC) Cause‐specific mortality after diagnosis of cancer among HIV‐positive patients: A collaborative analysis of cohort studies. International Journal of Cancer. 2020 Jun 1;146(11):3134-3146. doi: 10.1002/ijc.32895. Epub 2020 Mar 12

2019

L Gras, M May, LP Ryder, A Trickey, M Helleberg, N Obel, R Thiebaut, J Guest, J Gill, H Crane, V Dias Lima, A dʼArminio Monforte, TR Sterling, J Miro, S Moreno, C Stephan, C Smith, J Tate, L Shepherd, M Saag, A Rieger, D Gillor, M Cavassini, M Montero, SM Ingle, P Reiss, D Costagliola, FWNM Wit, J Sterne, F de Wolf, R Geskus; Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1-Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy. Antiretroviral Therapy Cohort Collaboration (ART-CC). J Acquir Immune Defic Syndr. 2019 Mar 1;80(3):292-300. doi: 10.1097/QAI.0000000000001913.

2018

R A Hughes, M T. Maya, K Tilling, N Taylorc, L Wittkop, P Reiss, J Gill, P Schommers, D Costagliolal J L. Guest, V D. Lima, A d’Arminio Monforte, C Smith, M Cavassini, M Saag, J L. Castilho and J AC Sterne. Long terms trends in CD4R cell counts, CD8R cell counts, and the CD4R :CD8R ratio. AIDS. 2018 Jun 19;32(10):1361-1367. doi: 10.1097/QAD.0000000000001848
Pettit A, Giganti M, Ingle SM, May MT, Shepherd BE, Gill MJ, Fatkenheuer G, Abgrall S, Saag MS, Del Amo J, Justice AC, Miro JM, Cavasinni M, Dabis F, Monforte AD, Reiss P, Guest J, Moore D, Shepherd L, Obel N, Crane HM, Smith C, Teira R, Zangerle R, Sterne JAC, Sterling TR, Antiretroviral Therapy Cohort Collaboration (ART-CC). Increased Non-AIDS Mortality among Persons with AIDS Defining Events after Antiretroviral Therapy Initiation. J Int AIDS Soc, 21 (1); 15 Jan 2018

2017

J Young, C Smith, R Teira, P Reiss, I Jarrín Vera I, H Crane, JM Miro, A d'Arminio Monforte, M Saag, R Zangerle, HC Bucher; Antiretroviral Therapy Cohort Collaboration (ART-CC). Antiretroviral pill count and clinical outcomes in treatment-naïve patients with HIV infection. HIV Med. 2018 Feb;19(2):132-142. doi: 10.1111/hiv.12562.
1. Trickey A, May MT, Schommers P, Tate J, Ingle S, Guest JL, Gill MJ, Zangerle R, Saag M, Reiss P, d'Arminio Monforte A, Johnson M, Lima VD, Sterling TR, Cavassini M, Wittkop L, Costagliola C, Sterne JAC, on behalf of the Antiretroviral Therapy Cohort Collaboration (ART-CC). CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus–Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC). Clinical Infectious Diseases 65 (6); 15 Sep 2017
1. Trickey A, May MT, Vehreschild J-J, Obel N, Gill MJ, Crane HM, Boesecke C, Patterson S, Grabar S, Cazanave C, Cavassini M, Shepherd L, d'Arminio Monforte A, van Sighem A, Saag MS, Lampe FC, Hernando V, Montero M, Zangerle R, Justice AC, Sterling TR, Ingle S, & Sterne J. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. The Lancet HIV, epub before print; 10 May 2017

2016

Balestre E, Ekouevi DK, Tchounga B, Eholie SP, Messou E, Sawadogo A, Thiébaut R, May MT, Sterne JA, Dabis F; International Epidemiological Database to Evaluate AIDS (IeDEA) West Africa Collaboration. Immunologic response in treatment-naïve HIV-2-infected patients: the IeDEA West Africa cohort. J Int AIDS Soc. 19(1):20044; 8 Feb 2016
Trickey A, May MT, Vehreschild J, Obel N, Gill MJ, Crane H, Boesecke C, Samji H, Grabar S, Cazanave C, Cavassini M, Shepherd L, d'Arminio Monforte A, Smit C, Saag M, Lampe F, Hernando V, Montero M, Zangerle R, Justice AC, Sterling T, Miro J, Ingle S, Sterne JA. Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy. PLoS One. 11(8):e0160460; 15 Aug 2016
2. May MT, Vehreschild JJ, Trickey A, Obel N, Reiss P, Bonnet F, Mary-Krause M, Samji H, Cavassini M, Gill MJ, Shepherd LC, Crane HM, d'Arminio Monforte A, Burkholder GA, Johnson MM, Sobrino-Vegas P, Domingo P, Zangerle R, Justice AC, Sterling TR, Miro JM, Sterne JA. Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study Clin Infect Dis. 62(12):1571-7; 15 Jun 2016
Antiretroviral Therapy Cohort Collaboration (ART-CC), Canadian Observational Cohort Collaboration (CANOC), The UK Collaborative HIV Cohort Study (UK CHIC), the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) Mortality of treated HIV-1 positive individuals according to viral subtype in Europe and Canada: collaborative cohort analysis. AIDS 30(3):503-13; 28 Jan 2016
1. Cain LE, Saag MS, Petersen M, May MT, Ingle SM, Logan R, Robins JM, Abgrall S, Shepherd BE, Deeks SG, Gill MJ, Touloumi G, Vourli G, Dabis F, Vandenhende MA, Reiss P, van Sighem A, Samji H15, Hogg RS16, Rybniker J17, Sabin CA18, Jose S18, Del Amo J19, Moreno S20, Rodríguez B, Cozzi-Lepri A, Boswell SL, Stephan C, Pérez-Hoyos S, Jarrin I, Guest JL, Monforte AD, Antinori A, Moore R, Campbell CN, Casabona J, Meyer L, Seng R, Phillips AN, Bucher HC, Egger M, Mugavero MJ, Haubrich R, Geng EH, Olson A, Eron JJ, Napravnik S, Kitahata MM, Van Rompaey SE, Teira R, Justice AC, Tate JP, Costagliola D, Sterne JA, Hernán MA; Antiretroviral Therapy Cohort Collaboration, the Centers for AIDS Research Network of Integrated Clinical Systems, and the HIV-CAUSAL Collaboration. Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy. IJE 44 (6); 31 Dec 2015

2015

Antiretroviral Therapy Cohort Collaboration (ART-CC). Sex differences in overall and cause-specific mortality among HIV-infected adults on antiretroviral therapy in Europe, Canada and the US. Antivir Ther. 2015;20(1):21-8. doi: 10.3851/IMP2768.
MA Vandenhende, S Ingle, M May, G Chene, R Zangerle, A Van Sighem, MJ Gill, C Schwarze-Zander, B Hernandez-Novoa, N Obel, O Kirk, S Abgrall, J Guest, H Samji, A d'Arminio Monforte, JM Llibre, C Smith, M Cavassini, GA Burkholder, B Shepherd, HM Crane, J Sterne, P Morlat Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients. AIDS. 2015 Jan 28;29(3):373-83
M Helleberg, MT May, SM Ingle, F Dabis, P Reiss, G Fätkenheuer, D Costagliola, S d'Arminio Monforte, M Cavassini, C Smith, AC Justice, J Gill, JA Sterne, N Obel. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. AIDS. 2015 Jan 14;29(2):221-9

2014

FN Engsig, R Zangerle, O Katsarou, F Dabis, P Reiss, J Gill, K Porter, C Sabin, A Riordan, G Fätkenheuer, F Gutiérrez, F Raffi, O Kirk, M Mary-Krause, C Stephan, PG de Olalla, J Guest, H Samji, A Castagna, A d'Arminio Monforte, A Skaletz-Rorowski, J Ramos, G Lapadula, C Mussini, L Force, L Meyer, F Lampe, F Boufassa, HC Bucher, S De Wit, GA BurkholderA, R Teira, AC Justice, TR Sterling, H M Crane, J Gerstoft, J Grarup, M May, G Chêne, SM Ingle, J Sterne, N Obel; Antiretroviral Therapy Cohort Collaboration (ART-CC) and the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. Long-term mortality in HIV positive individuals virally suppressed for more than three years with incomplete CD4 recovery CID 58(9): 1312-21. May 2014
SM Ingle, MT May, MJ Gill, MJ Mugavero, C Lewden, S Abgrall, G Fätkenheuer, P Reiss, MS Saag, C Manzardo, S Grabar, M Bruyand, D Moore, A Mocroft, TR Sterling, A d'Arminio Monforte, V Hernando, R Teira, J Guest, M Cavassini, HM Crane, JAC Sterne & for the Antiretroviral Therapy Cohort Collaboration. Impact of risk factors for specific causes death in the first and subsequent years of ART among HIV-infected patients. CID 59(2): 287-97. 15 July 2014
The IeDEA and ART Cohort Collaborations Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr 2014;65:e8-e16
A Boulle, M Schomaker, MT May, R Hogg, BE Shepherd, S Monge, O Keiser, F Lampe, J Giddy, J Ndirangu, D Garone, M Fox, SM Ingle, P Reiss, F Dabis, D Costagliola, A Castagna, K Ehren, C Campbell, MJ Gill, M Saag, AC Justice, J Guest, H Crane, M Egger, Sterne JAC. Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe or North America: a collaborative analysis of prospective studies . PLoS Med 11(9): e1001718. 9 Sept 2014

2013

JP Tate, AC Justicea, MD Hughesb, F Bonnetc, P Reissd, A Mocrofte, J Nattermannf, FC Lampee, HC Bucherg, TR Sterlingh, HM Cranei, MM Kitahataj, M Mayk and JAC Sterne. An internationally generalizable risk index for mortality after one year of antiretroviral therapy AIDS 2013, 27:563-572
J Kaulich-Bartz, W Dam, MT May, B Lederberger, U Widmer, AN Phillips, S Grabar, A Mocroft, J Vilaro, A van Sighem, S Moreno, F Dabis, AD Monforte, R Teira, SM Ingle, JA Sterne. Writing committee for the Antiretroviral Cohort Collaboration. Insurability of HIV positive people treated with antiretroviral therapy in Europe: collaborative analysis of HIV cohort studies. AIDS. 2013; 27:1641-1655
The Antiretroviral Therapy Cohort Collaboration (ART-CC) Higher rates of AIDS during the first year of antiretroviral therapy among migrants: the importance of tuberculosis AIDS 2013, 27:1321-1329
The Antiretroviral Therapy Cohort Collaboration (ART-CC) Influence of geographical origin and ethnicity on mortality in patients on antiretroviral therapy in Canada, Europe, and the United States. Clin Infect Dis. (2013) 56 (12): 1800-1809

2012

MT May, RS Hogg, AC Justice, BE Shepherd, D Costagliola, B Ledergerber, R Thiébaut, MJ Gill, O Kirk, A van Sighem, MS Saag, G Navarro, P Sobrino-Vegas, F Lampe, S Ingle, JL Guest, HM Crane, A d'Arminio Monforte, JJ Vehreschild, JA Sterne; the Collaboratin Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics. Int J Epidemiol. 2012 Dec;41(6):1807-1820

2011

MJ Mugavero, M May, HJ Ribaudo, RM Gulick, SA Riddler, R Haubrich, S Napravnik, S Abgrall, A Phillips, R Harris, MJ Gill, F de Wolf, R Hogg, HF Günthard, G Chêne, A d'Arminio Monforte, JL Guest, C Smith, J Murillas, J Berenguer, C Wyen, P Domingo, MM Kita Comparative effectiveness of initial antiretroviral therapy regimens: ACTG 5095 and 5142 clinical trials relative to ART-CC cohort study. JAIDS 58(3):253-260
M Murray, R Hogg, V Lima, M May, D Moore, S Abgrall, M Bruyand, A d'Arminio Monforte, C Tural, M Gill, R Harris, P Reiss, A Justice, O Kirk, M Saag, C Smith, R Weber, J Rockstroh, P Khaykin, J Sterne; for the Antiretroviral Therapy Cohort Collaboration (ART-CC) The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis. HIV Medicine 13(2):89-97

2010

Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010 May 15;50(10):1387-96

2009

DM Moore, R Harris, V Lima, B Hogg, M May, B Yip, A Justice, A Mocroft, P Reiss, F Lampe, G Chêne, D Costagliola, L Elzi, MJ Mugavero, AD Monforte, C Sabin, D Podzamczer, G Fätkenheuer, S Staszewski, J Gill, JA Sterne; Antiretroviral Therapy Cohort Collab Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression. J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):357-63
Antiretroviral Cohort Collaboration (ART-CC) Writing committee: RJ Harris, JAC Sterne, S Abgrall, F Dabis, P Reiss, M Saag, AN Phillips, G Chêne, JM Gill, AC Justice, J Rockstroh, CA Sabin, A Mocroft, HC Bucher, RS Hogg, A d'Arminio Monforte, M May, M Egg Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in eight industrialized countries. Int J Epidemiol. 2009 Dec, 38(6):1624-33
RJ Harris, JA Sterne, S Abgrall, F Dabis, P Reiss, M Saag, AN Phillips, G Chêne, JM Gill, AC Justice, J Rockstroh, CA Sabin, A Mocroft, HC Bucher, RS Hogg, AD Monforte, M May, M Egger; Antiretroviral Therapy Cohort Collaboration. Prognostic importance of anaemia in HIV-1 infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies in industrialized countries. Antiviral Therapy 2009;13: 959-967
Antiretroviral therapy cohort collaboration (ART-CC), E Lanoy, M May, A Mocroft, A Phillip, A Justice, G Chêne, H Furrer, T Sterling, AD Monforte, L Force, J Gill, R Harris, RS Hogg, J Rockstroh, M Saag, P Khaykin, F de Wolf, JA Sterne, D Costagliola. Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements. AIDS. 2009 Oct 23;23(16):2199-208
When To Start Consortium Writing Committee: JAC Sterne, M May, D Costagliola, F de Wolf, AN Phillips, R Harris, MJ Funk, RB Geskus, J Gill, F Dabis, JM Miro, AC Justice, B Ledergerber, G Fatkenheuer, RS Hogg, A d'Arminio Monforte, M Saag, C Smith, S Stasz Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet. 2009 Apr 18;373(9672):1352-63
The ART Cohort Collaboration Writing committee: A Mocroft, J Sterne, M Egger, M May, S Grabar, H Furrer, C Sabin, G Fatkenheuer, A Justice, P Reiss, A d'Arminio Monforte, J Gill, R Hogg, F Bonnet, M Kitahata, S Staszewski, J Casabona, R Harris, M Saag. Variable impact on mortality of AIDS defining events diagnosed during combination antiretroviral therapy: Not all AIDS Defining Conditions are Created Equal. Clinical Infectious Diseases 2009 Apr 15;48(8):1138-51

2008

The ART Cohort Collaboration Writing committee: R Harris, R Hogg, D Costagliola, M May, F de Wolf, J Gill, G Fätkenheuer, C Lewden, M Saag, S Staszewski, A d'Arminio Monforte, J Casabona, F Lampe, A Justice, V von Wyl, M Egger. Prognostic importance of anaemia in HIV-1 infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies in industrialized countries. Antivir Therapy 2008; 13(8):959-67
The ART Cohort Collaboration: Writing committee: R Hogg, V Lima, JAC Sterne, S Grabar, M Battegay, M Bonarek, A d'Arminio Monforte, A Esteve, MJ Gill, R Harris, A Justice, A Hayden, F Lampe, A Mocroft, MJ Mugavero, S Staszewski, JC Wasmuth, A van Sighem, Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 2008; 372: 293-299
The ART Cohort Collaboration: Writing committee: MJ Mugavero, M May, R Harris, MS Saag, D Costagliola, M Egger, A Phillips, H Günthard, F Dabis, R Hogg, F de Wolf, G Fatkenheuer, J Gill, A Justice, A d'Arminio Monforte, F Lampe, JM Miró, S Staszewski, M K Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice? AIDS 2008; 22: 2481-2492

2007

The Antiretroviral Therapy Cohort (ART) Collaboration- Writing committee: JAC Sterne, MT May, CA Sabin, AN Phillips, D Costigliola, J Chene, AC Justice, F De Wolf, RS Hogg, M Battegay, A d'Arminio Monforte, G Fatkenheuer, S Staszewski, J Gill, M Egger. Importance of baseline prognostic factors with increasing time since initiation of Highly Active Antiretroviral Therapy. Collaborative analysis of cohorts of HIV-1 infected patients. J Acquir Defic Syndr. 2007; 46: 607-615
The ART Cohort Collaboration - Writing committee: M May, J Sterne, C Sabin, D Costagliola, A Justice, R Thiébaut, J Gill, A Phillips, P Reiss, R Hogg, B Ledergerber, A d'Arminio Monforte, N Schmeisser, S Staszewski, M Egger. Prognosis of HIV-1 infected patients up to five years after initiation of HAART: collaborative analysis of prospective studies. AIDS 2007; 21:1185-1197

2006

ART Cohort Collaboration Study- Writing committee: MT May, JAC Sterne, D Costagliola, CA Sabin, AN Phillips, AC Justice, F Dabis, J Gill, J Lundgren, RS Hogg, F de Wolf, G Fätkenheuer, S Staszewski, A d'Arminio Monforte, M Egger for The Antiretroviral The HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis. Lancet. 2006 Aug 5;368(9534):451-8.

2005

A d'Arminio Monforte, CA Sabin, A Phillips, JAC Sterne, M May, AC Justice et al. The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy. Arch.Intern Med 2005; 165:416-23
E Girardi, CA Sabin, A d'Arminio Monforte, B Hogg, AN Phillips, MJ Gill, F Dabis, P Reiss, O Kirk, E Bernasconi, S Grabar, A Justice, S Staszewski, G Fatkenheuer, JA Sterne for the Antiretroviral Therapy Cohort Collaboration. Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. Clin Infect Dis 2005; 41: 1772-1782
M May, P Kholoud, JAC Sterne, P Royston, M Egger, ART-CC (The Antiretroviral Therapy Cohort Collaboration) and CASCADE (Concerted Action on SeroConversion to AIDS and Death in Europe). Prognostic model for HIV-1 disease progression in patients starting antiretroviral therapy was validated using independent data. J Clin Epidemiol 2005; 58:1033-1041
C Sabin, B Hogg, F Dabis, MJ Gill, AN Phillips, P Reiss, G Fätkenheuer, S Grabar, J Lundgren, A Justice, B Ledergerber, A d'Arminio Monforte, A Staszewski and Sterne JAC for The ART Cohort Collaboration. AIDS events among individuals initiating HAART: do some patients experience a greater benefit from HAART than others? AIDS 2005 19: 1995-2000

2004

M May, P Royston, M Egger, AC Justice, JAC Sterne, ART Cohort Collaboration. Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapy. Statistic in Medicine 2003; 23:2375-98

2003

The Antiretroviral Therapy (ART) Cohort Collaboration. Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies. Lancet 2003, 362:679-86

2002

M Egger, M May, G Chêne, AN Phillips, B Ledergerber, F Dabis, D Costagliola, A d'Arminio Monforte, F de Wolf, P Reiss, JD Lundgren, AC Justice, S Staszewski, C Leport, RS Hogg, CA Sabin, M J Gill, B Salzberger, JAC Sterne and the ART Cohort Collaboration. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002;360:119-29

Publications

La raccolta di tutte le pubblicazioni di Fondazione ICONA,...

ART Cohort Collaboration